M. Genoni et al., Chronic beta-blocker therapy improves outcome and reduces treatment costs in chronic type B aortic dissection, EUR J CAR-T, 19(5), 2001, pp. 606-610
Objectives: To compare the medical treatment of chronic type B aortic disse
ction with beta -blockers versus other antihypertensive treatments in terms
of their requirement for surgical intervention and treatment costs. Method
s: Case records of the 130 patients treated for aortic dissection type B in
this unit between 1988 and 1997 were reviewed. Seventy-eight of 130 patien
ts with chronic dissection have received isolated medical treatment. Sevent
y-one of 78 patients were discharged alive. Fifty-one of 71 received beta -
blocker treatment, 20/71 were treated with other antihypertensive drugs. Re
sults: Surgery for aortic dissection became necessary in 20/71 patients (28
%) during follow-up (mean, 4.2 years): 10/51 in the beta -blocker group and
9/20 in the other antihypertensive drug group. The freedom from subsequent
aortic operation was 80 and 47%, respectively (P = 0.001). Indications for
emergency surgery were increased aortic diameter (79%), symptomatic aortic
aneurysm (11%), and renal artery hypoperfusion (5%). The median hospitaliz
ation time during follow-up (dissection-related) was 2 days for patients wh
o received beta -blockers and 16 days for patients who received other antih
ypertensive drug treatments (P = 0.001). The cost of treatment/patient per
year amounted to 644 and 12 748 euros, respectively. Conclusions: A substan
tial proportion of patients with chronic type B dissection who receive init
ial medical management will later need surgery. Long-term treatment with be
ta -blockers reduces the progression of aortic dilatation, the incidence of
subsequent hospital admissions, as well as the incidence of late dissectio
n-related aortic procedures and the cost of treatment. Patients with chroni
c type B dissection need, in addition to frequent follow-up of aortic diame
ter, continuous treatment with beta -blocking agents. (C) 2001 Elsevier Sci
ence B.V. All rights reserved.